Literature DB >> 17142792

Conflicts of interest in biomedical research--the FASEB guidelines.

Laura M Brockway1, Leo T Furcht.   

Abstract

The rise in academia-industry relationships has been accompanied by increasing concerns about financial conflicts of interest. To date, policy recommendations addressing financial conflicts of interest have focused on the role of academic institutions in reviewing and overseeing investigator relationships with industry. However, investigators as a group determine the effectiveness of policies and practices. Therefore, there is a clear need for a consensus statement of standards for academia-industry interactions from the scientists' perspective. To meet that need, we propose conflict of interest guidelines for individual biomedical investigators to address the critical challenges faced when financial relationships with industry exist.

Mesh:

Year:  2006        PMID: 17142792     DOI: 10.1096/fj.06-6723LSF

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  4 in total

1.  Institutional financial conflicts of interest policies at Canadian academic health science centres: a national survey.

Authors:  Paula A Rochon; Melanie Sekeres; Joel Lexchin; David Moher; Wei Wu; Sunila R Kalkar; Marleen Van Laethem; John Hoey; An-Wen Chan; Andrea Gruneir; Jennifer Gold; James Maskalyk; David L Streiner; Nathan Taback; Lorraine E Ferris
Journal:  Open Med       Date:  2010-07-06

Review 2.  Enhancing credibility of chemical safety studies: emerging consensus on key assessment criteria.

Authors:  James W Conrad; Richard A Becker
Journal:  Environ Health Perspect       Date:  2010-12-15       Impact factor: 9.031

3.  Conrad and Becker's "10 Criteria" fall short of addressing conflicts of interest in chemical safety studies.

Authors:  Patrice Sutton; Tracey J Woodruff; Sarah Vogel; Lisa A Bero
Journal:  Environ Health Perspect       Date:  2011-12       Impact factor: 9.031

4.  The problems with forbidding science.

Authors:  Gary E Marchant; Lynda L Pope
Journal:  Sci Eng Ethics       Date:  2009-04-07       Impact factor: 3.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.